
1. mol biochem parasitol. 2012 dec;186(2):143-7. doi:
10.1016/j.molbiopara.2012.10.004. epub 2012 oct 27.

a transgenic plasmodium falciparum nf54 strain expresses gfp-luciferase
throughout parasite life cycle.

vaughan am(1), mikolajczak sa, camargo n, lakshmanan v, kennedy m, lindner se,
miller jl, hume jc, kappe sh.

author information: 
(1)seattle biomedical research institute, seattle, wa, usa.
ashley.vaughan@seattlebiomed.org

plasmodium falciparum pathogenic agent lethal human
malarias. transgenic p. falciparum parasites expressing luciferase been
created study drug interventions asexual sexual blood stages but
luciferase-expressing mosquito stage liver stage parasites been
created prevented easy quantification mosquito stage development
(e.g. transmission blocking interventions) liver stage development (for
interventions prevent infection). overcome obstacle, created
a transgenic p. falciparum nf54 parasite expresses gfp-luciferase
transgene throughout life cycle. luciferase expression robust and
measurable life cycle stages, including midgut oocyst, salivary gland
sporozoites liver stages, vivo development easily measurable
using humanized mouse infections conjunction vivo imaging system.
this parasite reporter strain accelerate testing interventions against
pre-erythrocytic life cycle stages.

copyright Â© 2012 elsevier b.v. rights reserved.

doi: 10.1016/j.molbiopara.2012.10.004 
pmid: 23107927  [indexed medline]

